Recommendations guide for patients with diabetes mellitus and cardiovascular disease
DOI:
https://doi.org/10.47196/diab.v55i1Sup.465Keywords:
consensus, diabetes, cardiovascular diseasesAbstract
Faced with the significant and rapid changes in knowledge related to the pathophysiology of diabetes mellitus (DM) and the mechanisms involved in the development of cardiovascular diseases (CVD), on the one hand, and, on the other, with the development of different drugs with unexpected effects at the cardiovascular level, we set out to develop an updated consensus between the Argentine Society of Cardiology and the Argentine Society of Diabetes, two societies with recognized trajectory in the preparation of guidelines and consensus that, ultimately, have the objective of providing a material updated and practical for the management of patients with DM and CVD. Although our joint task had begun some time ago, this Consensus comes to light in the middle of one of the worst health crises in the world with the emergence of SARS-CoV2 and its clinical manifestation, COVID-19.
References
I. Cuarta Encuesta Nacional de Factores de Riesgo. Argentina: Ministerio de Salud; 2019. Disponible en: http://www.msal.gob.ar/images/stories/bes/graficos/0000001444cnt-2019-04_4ta-encuesta-nacional-factores-riesgo.pdf.
II. Paneni F, Beckman JA, Creager MA, Cosentino F. DM and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I. Eur Heart J 2013; 34:2436-2443.
III. Einarson TR, Acs A, Ludwig C, Panton UH. Prevalence of cardiovascular disease in type 2 DM: a systematic literature review of scientific evidence from across the world in 2007-2017. Cardiovasc Diabetol 2018; 17(83):1-19.
IV. Rawshani A, Rawshani A, Franzén S, Eliasson B, Svensson AM, Miftaraj M, McGuire DK, Sattar N, Rosengren A, Gudbjörnsdottir S. Mortality and cardiovascular disease in type 1 and type 2 DM. N Engl J Med 2017 Apr 13; 376(15):1407-1418.
V. Global Burden of Disease Study. Institute for Health Metrics and Evaluations. Washington: University of Washington; 2017. Disponible en: http://ghdx.healthdata.org/gbd-results-tool.
VI. Caporale JE, Elgart JF, Gagliardino JJ. DM in Argentina: cost and management of DM and its complications and challenges for health policy. Globalization and Health 2013; 9:54.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 on behalf of the authors. Reproduction rights: Argentine Diabetes Society
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Dirección Nacional de Derecho de Autor, Exp. N° 5.333.129. Instituto Nacional de la Propiedad Industrial, Marca «Revista de la Sociedad Argentina de Diabetes - Asociación Civil» N° de concesión 2.605.405 y N° de disposición 1.404/13.
La Revista de la SAD está licenciada bajo Licencia Creative Commons Atribución – No Comercial – Sin Obra Derivada 4.0 Internacional.
Por otra parte, la Revista SAD permite que los autores mantengan los derechos de autor sin restricciones.
